Dimethyl fumarate and teriflunomide for multiple sclerosis in a real-life setting: a French retrospective cohort study.

S CondéXavier MoissetB PereiraM ZuelR ColamarinoM Maillet-VioudM LauxeroisF TaitheP Clavelounull null

Published in: European journal of neurology (2018)

In this retrospective cohort study, DMF demonstrated significantly better efficacy over 2 years than teriflunomide, but tolerance to teriflunomide was better.

Keyphrases

multiple sclerosis
white matter